That's the thing for me- how unique is this companies' test kit?
I've done a lot of research on this and I think it's a case of right place right time for this diagnostic company with covid but there are lots of competitors that have usability strengths.
So far, according to studies, it doesn't seem to be the "first there was black-and-white TV, we are color TV" gap that the management claims. No evidence to support this claim that I have seen. Lots of evidence show other tests performing as well.
I think they will do well and I still think that usability is a really important thing. This is the reason why I invested in this company. They are the only infectious disease home self test to date in this country. Great first mover advantage. But according to my research there is lots of competition with very similar performance.
- Forums
- ASX - By Stock
- AT1
- Ann: Atomo and Access Bio renegotiate supply agreements
Ann: Atomo and Access Bio renegotiate supply agreements, page-17
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $13.42M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.0¢ | $8.115K | 394.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 650696 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 5440 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 650696 | 0.020 |
5 | 340742 | 0.019 |
5 | 450453 | 0.018 |
5 | 735888 | 0.017 |
1 | 200001 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 5440 | 1 |
0.023 | 670706 | 2 |
0.024 | 270000 | 4 |
0.025 | 332555 | 3 |
0.026 | 995368 | 3 |
Last trade - 14.22pm 15/11/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online